Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Desmoid Tumors × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 8 Glioblastoma 8 Polycythemia Vera 7 Meningioma 7 Leukemia, Myeloid, Acute 7 Head and Neck Neoplasms 7 Gliosarcoma 6 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2 Treatment-Refractory Solid Tumors 1 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombosis 1 Thrombocytosis 1

Interventions

nirogacestat 8 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 Cryosurgery 3 X-Rays 2 Toremifene 2 Phantoms, Imaging 2 Nivolumab 2 Blood Specimen Collection 2 strattice 1 liposomal doxorubicin 1 entinostat 1 anlotinib 1 Vinblastine 1 Taxes 1 Tamoxifen 1 Surveys and Questionnaires 1 Sunitinib 1 Sulindac 1 Sorafenib 1 Saline Solution 1 Radiotherapy 1 Radiofrequency Ablation 1 Pregnancy 1 Methotrexate 1 Ipilimumab 1 Hydroxyurea 1 High-Intensity Focused Ultrasound Ablation 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡